Fentanyl Patch 75mcg/hr

Fentanyl Transdermal Patch 75mcg/hr: Medical Use and Safety Guide

Fentanyl transdermal patches 75mcg/hr are a potent opioid delivery system designed for patients with chronic, around-the-clock pain requiring continuous opioid management.

Medical Indications and Purpose

• Approved Use: Management of persistent, moderate-to-severe chronic pain

• Patient Criteria: Opioid-tolerant patients only (≥60mg oral morphine/day equivalent)

• Pain Types: Typically for cancer pain, chronic neuropathic pain, or end-stage conditions

• Administration: Continuous 72-hour transdermal delivery

Dosage and Pharmacokinetics

• Delivery Rate: 75 micrograms per hour continuously

• Therapeutic Onset: 12-24 hours after initial application

• Steady State: Achieved after approximately 3-6 days

• Duration: Designed for 72-hour wear time

• Absorption: Continues for 24+ hours after patch removal

Critical Safety Information

Black Box Warnings:

• Life-threatening respiratory depression

• Accidental exposure can be fatal

• Not for acute/post-operative pain

• Not for opioid-naïve patients

Application Guidelines:

• Apply to intact, non-irritated skin on upper body

• Rotate application sites between doses

• Avoid heating pads or direct heat sources

• Ensure firm adhesion for full 72 hours

Serious Risks and Side Effects

Common Side Effects:

• Nausea and constipation

• Drowsiness and dizziness

• Local skin reactions

• Sweating and dry mouth

Serious Adverse Effects:

• Respiratory depression

• Hypotension and bradycardia

• Adrenal insufficiency

• Serotonin syndrome (with concurrent serotonergic drugs)

Patient Safety Instructions

Proper Use:

• Use exactly as prescribed – never increase dosage frequency

• Never cut or damage the patch

• Wash hands after application

• Dispose of used patches properly (fold sticky sides together)

Emergency Signs Requiring Medical Help:

• Slow or difficult breathing

• Extreme drowsiness or confusion

• Fainting or dizziness

• Slow heartbeat

Important Contraindications

• Not for postoperative pain management

• Not for mild or intermittent pain

• Contraindicated in patients with:

  • Significant respiratory depression

  • Acute or severe bronchial asthma

  • Known gastrointestinal obstruction

Drug Interactions

Dangerous Combinations:

• Other opioid analgesics

• Benzodiazepines and sedatives

• Alcohol and CNS depressants

• MAO inhibitors (within 14 days)

• Certain antibiotics and antifungals

Overdose Management

Recognize Symptoms:

• Respiratory depression/arrest

• Extreme drowsiness progressing to coma

• Pinpoint pupils

• Cold, clammy skin

Emergency Response:

• Remove patch immediately

• Call 911 for emergency medical help

• Administer naloxone if available

• Provide respiratory support

Storage and Handling

• Store at room temperature

• Keep away from children and pets

• Dispose of properly to prevent accidental exposure

• Never share with another person

Special Populations

Use with Extreme Caution in:

• Elderly patients (increased sensitivity)

• Patients with renal/hepatic impairment

• Those with chronic pulmonary disease

• Patients with brain tumors or head injuries